TESTBANKFOR
nn nn
PATHOPHYSIOLOGY 5TH
nn
EDITION
nn
,01: Introduction to
nn nn
Pathophysiology
nn
Chapter nn01: nnIntroduction nnto
Pathophysiology nnTest nnBank
nn
MULTIPLE nnCHOICE
1. Which nnof nnthe nnfollowing nnwould nnbe nnthe nnmost nnlikely nncause nnof nnan nniatrogenic nndisease?
a. An nninherited nndisorder
b. A nncombination nnof nnspecific nnetiological nnfactors
c. An nnunwanted nneffect nnof nna nnprescribed nndrug
d. Prolonged nnexposure nnto nntoxic nnchemicals nnin nnthe nnenvironment
ANS: nnC nnREF: nn6
2. The nnmanifestations nnof nna nndisease nnare nnbest nndefined nnas nnthe:
a. subjective nnfeelings nnof nndiscomfort nnduring nna nnchronic nnillness.
b. signs nnand nnsymptoms nnof nna nndisease.
c. factors nnthat nnprecipitate nnan nnacute nnepisode nnof nna nnchronic nnillness.
d. early nnindicators nnof nnthe nnprodromal nnstage nnof nninfection.
ANS: nnB nnREF: nn6
3. The nnbest nndefinition nnof nnthe nnterm nnprognosis nnis nnthe:
a. precipitating nnfactors nncausing nnan nnacute nnepisode.
b. number nnof nnremissions nnto nnbe nnexpected nnduring nnthe nncourse nnof nna nnchronic nnillness.
,c. predicted nnoutcome nnor nnlikelihood nnof nnrecovery nnfrom nna nnspecific nndisease.
d. exacerbations nnoccurring nnduring nnchronic nnillness.
ANS: nnC nnREF: nn7
4. Which nnof nnthe nnfollowing nnis nnconsidered nna nnsystemic nnsign nnof nndisease?
a. Swelling nnof nnthe nnknee
b. Fever
c. Pain nnin nnthe nnneck
d. Red nnrash nnon nnthe nnface
ANS: nnB nnREF: nn6
5. Etiology nnis nndefined nnas nnthe nnstudy nnof nnthe:
a. causes nnof nna nndisease.
b. course nnof nna nndisease.
c. expected nncomplications nnof nna nndisease.
d. manifestations nnof nna nndisease.
ANS: nnA nnREF: nn5
6. A nntype nnof nncellular nnadaptation nnin nnwhich nnthere nnis nna nndecrease nnin nncell nnsize nnis nnreferred nnto nnas:
a. hypertrophy.
b. metaplasia.
, c. anaplasia.
d. atrophy.
ANS: nnD nnREF: nn8
7. A nnchange nnin nna nntissue nnmarked nnby nncells nnthat nnvary nnin nnsize nnand nnshape nnand nnshow nnincreased
nn mitotic nnfigures nnwould nnbe nncalled:
a. metaplasia.
b. atrophy.
c. dysplasia.
d. hypertrophy.
ANS: nnC nnREF: nn8
8. A nndeficit nnof nnoxygen nnin nnthe nncells nnusually nndue nnto nn respiratory nnor nncirculatory nnproblems nnis nncalled:
a. apoptosis.
b. ischemia.
c. hypertrophy.
d. necrosis.
ANS: nnB nnREF: nn9
9. When nna nngroup nnof nncells nnin nnthe nnbody nndies, nnthe nnchange nnis nncalled:
a. ischemia.
b. gangrene.
nn nn
PATHOPHYSIOLOGY 5TH
nn
EDITION
nn
,01: Introduction to
nn nn
Pathophysiology
nn
Chapter nn01: nnIntroduction nnto
Pathophysiology nnTest nnBank
nn
MULTIPLE nnCHOICE
1. Which nnof nnthe nnfollowing nnwould nnbe nnthe nnmost nnlikely nncause nnof nnan nniatrogenic nndisease?
a. An nninherited nndisorder
b. A nncombination nnof nnspecific nnetiological nnfactors
c. An nnunwanted nneffect nnof nna nnprescribed nndrug
d. Prolonged nnexposure nnto nntoxic nnchemicals nnin nnthe nnenvironment
ANS: nnC nnREF: nn6
2. The nnmanifestations nnof nna nndisease nnare nnbest nndefined nnas nnthe:
a. subjective nnfeelings nnof nndiscomfort nnduring nna nnchronic nnillness.
b. signs nnand nnsymptoms nnof nna nndisease.
c. factors nnthat nnprecipitate nnan nnacute nnepisode nnof nna nnchronic nnillness.
d. early nnindicators nnof nnthe nnprodromal nnstage nnof nninfection.
ANS: nnB nnREF: nn6
3. The nnbest nndefinition nnof nnthe nnterm nnprognosis nnis nnthe:
a. precipitating nnfactors nncausing nnan nnacute nnepisode.
b. number nnof nnremissions nnto nnbe nnexpected nnduring nnthe nncourse nnof nna nnchronic nnillness.
,c. predicted nnoutcome nnor nnlikelihood nnof nnrecovery nnfrom nna nnspecific nndisease.
d. exacerbations nnoccurring nnduring nnchronic nnillness.
ANS: nnC nnREF: nn7
4. Which nnof nnthe nnfollowing nnis nnconsidered nna nnsystemic nnsign nnof nndisease?
a. Swelling nnof nnthe nnknee
b. Fever
c. Pain nnin nnthe nnneck
d. Red nnrash nnon nnthe nnface
ANS: nnB nnREF: nn6
5. Etiology nnis nndefined nnas nnthe nnstudy nnof nnthe:
a. causes nnof nna nndisease.
b. course nnof nna nndisease.
c. expected nncomplications nnof nna nndisease.
d. manifestations nnof nna nndisease.
ANS: nnA nnREF: nn5
6. A nntype nnof nncellular nnadaptation nnin nnwhich nnthere nnis nna nndecrease nnin nncell nnsize nnis nnreferred nnto nnas:
a. hypertrophy.
b. metaplasia.
, c. anaplasia.
d. atrophy.
ANS: nnD nnREF: nn8
7. A nnchange nnin nna nntissue nnmarked nnby nncells nnthat nnvary nnin nnsize nnand nnshape nnand nnshow nnincreased
nn mitotic nnfigures nnwould nnbe nncalled:
a. metaplasia.
b. atrophy.
c. dysplasia.
d. hypertrophy.
ANS: nnC nnREF: nn8
8. A nndeficit nnof nnoxygen nnin nnthe nncells nnusually nndue nnto nn respiratory nnor nncirculatory nnproblems nnis nncalled:
a. apoptosis.
b. ischemia.
c. hypertrophy.
d. necrosis.
ANS: nnB nnREF: nn9
9. When nna nngroup nnof nncells nnin nnthe nnbody nndies, nnthe nnchange nnis nncalled:
a. ischemia.
b. gangrene.
